Semaglutide 5mg Research Product: Complete Scientific Overview

Order semaglutide 5mg vial. Semaglutide is a long-acting GLP-1 receptor agonist originally developed for type 2 diabetes and now widely researched for its effects on weight management, metabolic health, and neuroprotection. 

What Is Semaglutide?

Semaglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1) with structural modifications that extend its half-life and enhance receptor binding affinity. Order semaglutide 5mg vial

Key Product Identifiers

Mechanism of Action

Semaglutide acts as a selective, competitive GLP-1 receptor agonist with an EC50 of 6.2 pM, demonstrating potent receptor binding affinity. Order semaglutide 5mg vial

• Insulin Secretion: Stimulates glucose-dependent insulin release from pancreatic β-cells

• Glucagon Suppression: Inhibits glucagon secretion from pancreatic α-cells

• Gastric Emptying: Delays gastric emptying, promoting satiety

• Appetite Regulation: Reduces appetite through central GLP-1 receptor activation

• Mitochondrial Function: Regulates mitochondrial function and lipid metabolism

• Cellular Protection: Enhances autophagy and suppresses oxidative stress and apoptosis

The Aib (2-aminoisobutyric acid) residue at position 2 and the fatty acid side chain (C18 diacid conjugated via γGlu-AEEA-AEEA linkers) enable resistance to DPP-4 degradation and reversible albumin binding, extending the peptide’s half-life. 

Product Specifications: 5mg Format

Standard Product Content

Research-grade semaglutide is typically supplied as a lyophilized (freeze-dried) powder in vials containing 5mg of the peptide.

Reconstitution Information

Semaglutide is insoluble in water under standard conditions, but can be dissolved in:

Reconstitution Method:

1. Allow the vial to reach room temperature

2. Add calculated volume of appropriate solvent (e.g., 0.1M NaOH) to achieve desired concentration

3. Sonicate gently until completely dissolved

4. Aliquot and store at -80°C for long-term stability

How Many Doses in a 5mg Vial?

A 5mg vial contains enough peptide for multiple research doses, depending on the experimental design. For reference, clinical dosing schedules are as follows:

FDA-Approved Dosing Schedules 

Vial Yield Examples

• 0.25 mg/week dose:  20 weekly injections from one 5mg vial

• 0.5 mg/week dose: 10 weekly injections

• 1 mg/week dose: 5 weekly injections

Research Applications

Semaglutide has been investigated across a broad range of preclinical and clinical research areas:

Metabolic Research

• Type 2 Diabetes: Potent hypoglycemic effects through GLP-1 receptor activation

• Obesity: Dose-dependent weight reduction; in DIO mouse models, 100 nmol/kg resulted in 22% body weight decrease from 43.6g to 34.8g 

• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Regulation of lipid metabolism

Cardiovascular Research

In doxorubicin-induced cardiac toxicity models, semaglutide (12 μg/kg/day, 6 weeks) demonstrated:

• Significant improvement in cardiac function

• Reduced myocardial injury markers

• Increased survival rates

• Inhibition of oxidative stress and mitochondrial dysfunction 

Neurodegenerative Disease Research

Semaglutide has shown neuroprotective effects in:

• Parkinson’s Disease: In 6-OHDA-induced rat models, 25 nmol/kg semaglutide significantly improved neurological damage 

• Potential mechanisms: Suppression of oxidative stress, enhanced autophagy, regulation of mitochondrial function

Cancer Research

GLP-1 receptor pathways are being investigated for their role in cancer metabolism and cell proliferation.

Storage and Stability

Lyophilized Powder

• Temperature: -20°C ± 5°C

• Conditions: Sealed, desiccated, protected from light

• Stability: Up to 3 years when properly stored

Reconstituted Solution

• Short-term: -80°C for up to 1 year

• Avoid freeze-thaw cycles to prevent peptide degradation

Quality Considerations

Research-Grade Quality Standards

Premium semaglutide research products should include:

• HPLC purity analysis (≥98-99%)

• Mass spectrometry verification of molecular weight (~4114 Da)

• Third-party laboratory testing documentation

Manufacturing Standards

Products manufactured under:

• GMP (Good Manufacturing Practice) guidelines

• ISO 9001 certification

Research Dosage Guidance

Preclinical studies have utilized semaglutide across a range of dosages:

Switching from Other GLP-1 Agonists

For researchers modeling transitions between GLP-1 therapies, a conservative approach is recommended when switching from liraglutide (Saxenda®) to semaglutide: 

No washout period is required; semaglutide can be started the day after stopping liraglutide.

Summary of Key Research Applications